“Design and In Silico Evaluation of Novel 1,3,4-Oxadiazole Derivatives as Potential CYP51B Inhibitors Against Aspergillus fumigatus”, AJPS, vol. 26, no. 3, pp. 302–315, Sep. 2026, doi: 10.32947/ajps.v26i3.1420.